Spine surgery tech company SeaSpine Holdings (NASDAQ: SPNE) has agreed to acquire privately-held 7D Surgical for $110 million. The planned merger, announced March 22, comes more than a year after SeaSpine entered into a strategic alliance agreement to distribute Toronto-based 7D Surgical’s flagship navigational system. 7D Surgical has developed and commercialized advanced machine-vision-based registration algorithms to […]
SeaSpine
SeaSpine ticks up on 6.2% sales growth in Q4, reports losses
SeaSpine Holdings (NSDQ:SPNE) posted fourth-quarter results that missed the consensus forecast on Wall Street. The Carlsbad, Calif.-based company reported losses of $10.3 million, or -37¢ per share, on sales of $46.4 million for the three months ended Dec. 31, 2020, for a sales growth of 6.2% compared with Q4 2019. Earnings per share were -37¢, 12¢ […]
SeaSpine up on mixed-bag Q1 results
SeaSpine Holdings (NSDQ:SPNE) posted first-quarter results that beat the revenue consensus on Wall Street but missed on earnings. The company reported losses of -$12.6 million, or -48¢ per share on sales of $36.1 million for the three months ended March 31, for a sales loss of -0.1% compared with Q1 2019. Earnings per share were -48¢, […]
SeaSpine announces public offering
Spinal disorder treatment developer SeaSpine Holdings (NSDQ:SPNE) announced that it commenced an underwritten public offering of shares of its common stock. The Carlsbad, Calif.–based company plans to use the proceeds from the offering for working capital and other general corporate purposes. All shares in the offering are slated to be sold by SeaSpine. Piper Sandler and […]
SeaSpine shares rise on Q1 sales beat
Shares in SeaSpine Holdings (NSDQ:SPNE) rose today after the medical device maker beat sales expectations on Wall Street with its first quarter 2019 earnings results. The Carlsbad, Calif.-based company posted losses of approximately $9 million, or 48¢ per share, on sales of approximately $36.2 million for the three months ended March 31, seeing losses grow 26.5% […]
SeaSpine taps Cantor Fitzgerald for $50m offering
SeaSpine Holdings (NSDQ:SPNE) said late last week that inked a controlled equity offering sales agreement with Cantor Fitzgerald & Co., who will look to offer up to $50 million in the company’s shares. The stocks will be offered through an “at the market offering” program with Cantor Fitzgerald acting as the sales agent, according to an […]
SeaSpine posts Q4 EPS miss
Shares in SeaSpine Holdings (NSDQ:SPNE) are down slightly today after the medical device maker posted fourth quarter earnings there missed earnings-per-share expectations on Wall Street. The Carlsbad, Calif.-based company posted losses of $9.5 million, or 53¢ per share, on sales of $38 million for the three months ended December 31, seeing losses grow 26.9% while sales […]
Boston Scientific shares tick up after Q4 prelims meet estimates | Wall Street Beat
Shares in Boston Scientific (NYSE:BSX) rose slightly this morning after the company reported preliminary results for the fourth quarter and full year of 2018 that were in-line with estimates on Wall Street. The Marlborough, Mass.-based company said it expects to report $2.56 billion in sales for the fourth quarter and $9.82 billion for the full year. […]
SeaSpine posts mixed bag Q3
SeaSpine Holdings (NSDQ:SPNE) today posted third quarter earnings that beat sales expectations but missed on loss-per-share consensus on Wall Street. The Carlsbad, Calif.-based company posted losses of $9.5 million, or 65¢ per share, on sales of $35.8 million for the three months ended September 30, seeing losses grow 27.7% while sales grew 12.9% compared with the […]
SeaSpine posts mixed bag Q2
Shares in SeaSpine Holdings (NSDQ:SPNE) have stayed steady after the medical device maker posted second quarter earnings that topped Wall Street’s sales consensus but missed losses-per-share expectations. The Carlsbad, Calif.-based company posted losses of $7.4 million or 50¢ per share, on sales of $36.4 million for the three months ended June 30, seeing losses shrink 8% […]
NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]